CELLULAR BIOMEDICINE GROUP, INC.: 10-K filed 2017-03-13

Name: CELLULAR BIOMEDICINE GROUP, INC.: 10-K filed 2017-03-13
Creator: CELLULAR BIOMEDICINE GROUP, INC.
License: https://creativecommons.org/licenses/by/4.0/

What CELLULAR BIOMEDICINE GROUP, INC. reported in its annual report filed 2017-03-13 (fiscal FY 2016): 45 published measures, 148 facts as tagged in accession 0001654954-17-001934.

This filing

Form: 10-K (annual report)
Filed: 2017-03-13
Fiscal period: fiscal FY 2016
Accession: 0001654954-17-001934 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All CELLULAR BIOMEDICINE GROUP, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-12-31	68,628,467	USD
At 2015-12-31	49,460,422	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-12-31	2,734,513	USD
At 2015-12-31	3,095,486	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2016-12-31	65,893,954	USD
At 2015-12-31	46,364,936	USD
At 2014-12-31	39,156,091	USD
At 2013-12-31	15,395,073	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	-6,139,761	USD	92
2016-01-01 to 2016-12-31	-28,208,376	USD	366
2016-07-01 to 2016-09-30	-10,661,220	USD	92
2016-04-01 to 2016-06-30	-7,197,282	USD	91
2016-01-01 to 2016-03-31	-4,210,113	USD	91
2015-10-01 to 2015-12-31	-4,991,877	USD	92
2015-01-01 to 2015-12-31	-19,447,721	USD	365
2015-07-01 to 2015-09-30	-5,142,198	USD	92
2015-04-01 to 2015-06-30	-5,026,475	USD	91
2015-01-01 to 2015-03-31	-4,287,171	USD	90
2014-01-01 to 2014-12-31	-15,474,611	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-15,867,735	USD	366
2015-01-01 to 2015-12-31	-11,751,098	USD	365
2014-01-01 to 2014-12-31	-9,720,892	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	43,285,554	USD	366
2015-01-01 to 2015-12-31	19,647,152	USD	365
2014-01-01 to 2014-12-31	19,109,594	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-2,733,407	USD	366
2015-01-01 to 2015-12-31	-7,702,105	USD	365
2014-01-01 to 2014-12-31	-1,806,162	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-12-31	-85,546,687	USD
At 2015-12-31	-57,338,311	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	13,507,408	shares	366
2015-01-01 to 2015-12-31	11,472,306	shares	365
2014-01-01 to 2014-12-31	8,627,094	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	13,507,408	shares	366
2015-01-01 to 2015-12-31	11,472,306	shares	365
2014-01-01 to 2014-12-31	8,627,094	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	-0.43	USD/shares	92
2016-01-01 to 2016-12-31	-2.09	USD/shares	366
2016-07-01 to 2016-09-30	-0.75	USD/shares	92
2016-04-01 to 2016-06-30	-0.52	USD/shares	91
2016-01-01 to 2016-03-31	-0.35	USD/shares	91
2015-10-01 to 2015-12-31	-0.43	USD/shares	92
2015-01-01 to 2015-12-31	-1.7	USD/shares	365
2015-07-01 to 2015-09-30	-0.44	USD/shares	92
2015-04-01 to 2015-06-30	-0.44	USD/shares	91
2015-01-01 to 2015-03-31	-0.39	USD/shares	90
2014-01-01 to 2014-12-31	-1.79	USD/shares	365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	-0.43	USD/shares	92
2016-01-01 to 2016-12-31	-2.09	USD/shares	366
2016-07-01 to 2016-09-30	-0.75	USD/shares	92
2016-04-01 to 2016-06-30	-0.52	USD/shares	91
2016-01-01 to 2016-03-31	-0.35	USD/shares	91
2015-10-01 to 2015-12-31	-0.43	USD/shares	92
2015-01-01 to 2015-12-31	-1.7	USD/shares	365
2015-07-01 to 2015-09-30	-0.44	USD/shares	92
2015-04-01 to 2015-06-30	-0.44	USD/shares	91
2015-01-01 to 2015-03-31	-0.39	USD/shares	90
2014-01-01 to 2014-12-31	-1.79	USD/shares	365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-4,093	USD	366
2015-01-01 to 2015-12-31	728,601	USD	365
2014-01-01 to 2014-12-31	0	USD	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-12-31	4,117,739	USD
At 2015-12-31	2,768,900	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	5,452,417	USD	366
2015-01-01 to 2015-12-31	7,592,438	USD	365
2014-01-01 to 2014-12-31	2,528,885	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-28,415,334	USD	366
2015-01-01 to 2015-12-31	-20,848,970	USD	365
2014-01-01 to 2014-12-31	-12,442,484	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-12-31	40,692,084	USD
At 2015-12-31	16,694,291	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-12-31	2,364,036	USD
At 2015-12-31	3,019,257	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2016-12-31	216,154	USD
At 2015-12-31	260,886	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2016-12-31	7,678,789	USD
At 2015-12-31	7,678,789	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2016-12-31	39,974	USD
At 2015-12-31	630,332	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	29,043,264	USD	366
2015-01-01 to 2015-12-31	23,354,393	USD	365
2014-01-01 to 2014-12-31	13,006,861	USD	365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2016-12-31	0	USD
At 2015-12-31	390,886	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2016-10-01 to 2016-12-31	33,319	USD	92
2016-01-01 to 2016-12-31	-232,487	USD	366
2016-07-01 to 2016-09-30	884	USD	92
2016-04-01 to 2016-06-30	-251,988	USD	91
2016-01-01 to 2016-03-31	-14,702	USD	91
2015-10-01 to 2015-12-31	75,543	USD	92
2015-01-01 to 2015-12-31	625,092	USD	365
2015-07-01 to 2015-09-30	181,491	USD	92
2015-04-01 to 2015-06-30	258,730	USD	91
2015-01-01 to 2015-03-31	109,328	USD	90
2014-01-01 to 2014-12-31	322,162	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	11,475,587	USD	366
2015-01-01 to 2015-12-31	7,573,228	USD	365
2014-01-01 to 2014-12-31	3,146,499	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-12-31	14,281,378	shares
At 2015-12-31	11,711,645	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-12-31	152,543,052	USD
At 2015-12-31	103,807,651	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2016-12-31	-1,116,692	USD
At 2015-12-31	-116,115	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2016-12-31	6,675,718	USD
At 2015-12-31	4,954,766	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2016-12-31	2,557,979	USD
At 2015-12-31	2,185,866	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2016-12-31	1,168,787	USD
At 2015-12-31	845,087	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2016-12-31	986,951	USD
At 2015-12-31	367,050	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2016-12-31	459	USD
At 2015-12-31	29,673	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-28,204,283	USD	366
2015-01-01 to 2015-12-31	-20,176,322	USD	365
2014-01-01 to 2014-12-31	-12,355,459	USD	365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-29,208,953	USD	366
2015-01-01 to 2015-12-31	-21,132,211	USD	365
2014-01-01 to 2014-12-31	-13,848,312	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	11,670,506	USD	366
2015-01-01 to 2015-12-31	13,068,255	USD	365
2014-01-01 to 2014-12-31	7,875,413	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	850,793	USD	366
2015-01-01 to 2015-12-31	573,015	USD	365
2014-01-01 to 2014-12-31	586,679	USD	365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	132,108	USD	366
2015-01-01 to 2015-12-31	630,428	USD	365
2014-01-01 to 2014-12-31	71,982	USD	365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	211,051	USD	366
2015-01-01 to 2015-12-31	672,648	USD	365
2014-01-01 to 2014-12-31	87,025	USD	365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	4,093	USD	366
2015-01-01 to 2015-12-31	-728,601	USD	365
2014-01-01 to 2014-12-31	50,745	USD	365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	0	USD	366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	42,399,874	USD	366
2015-01-01 to 2015-12-31	18,964,849	USD	365
2014-01-01 to 2014-12-31	19,121,956	USD	365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-537,155	USD	366
2015-01-01 to 2015-12-31	497,937	USD	365
2014-01-01 to 2014-12-31	-20,645	USD	365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-514,734	USD	366
2015-01-01 to 2015-12-31	142,486	USD	365
2014-01-01 to 2014-12-31	78,310	USD	365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-28,205	USD	366
2015-01-01 to 2015-12-31	-166,032	USD	365
2014-01-01 to 2014-12-31	165,517	USD	365

Inspect the source

Entity: CELLULAR BIOMEDICINE GROUP, INC. / CIK 0001378624
Captured: 2026-09-22 19:45 UTC
SEC response SHA-256: b44d08863d62569e9fd817107b545bcd8036e0b5a0651202c09ca062cee0088a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001378624.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))